1. Home
  2. GRDX vs MYSE Comparison

GRDX vs MYSE Comparison

Compare GRDX & MYSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GridAI Technologies Corp.

GRDX

GridAI Technologies Corp.

N/A

Current Price

$2.06

Market Cap

7.3M

Sector

Health Care

ML Signal

N/A

Logo Myseum Inc.

MYSE

Myseum Inc.

HOLD

Current Price

$1.47

Market Cap

7.5M

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRDX
MYSE
Founded
N/A
2014
Country
United Kingdom
United States
Employees
2
10
Industry
Biotechnology: Pharmaceutical Preparations
Telecommunications Equipment
Sector
Health Care
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
7.3M
7.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
GRDX
MYSE
Price
$2.06
$1.47
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
77.8K
52.2K
Earning Date
05-14-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.87
$1.31
52 Week High
$5.30
$3.40

Technical Indicators

Market Signals
Indicator
GRDX
MYSE
Relative Strength Index (RSI) 44.52 40.20
Support Level $1.99 $1.45
Resistance Level $2.60 $2.13
Average True Range (ATR) 0.21 0.13
MACD 0.01 -0.01
Stochastic Oscillator 18.84 29.17

Price Performance

Historical Comparison
GRDX
MYSE

About GRDX GridAI Technologies Corp.

GridAI Technologies Corp, formerly known as Entero Therapeutics Inc, is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The company's programs address unmet needs in GI health and include: latiglutenase, a Phase 3-ready, potentially first-in-class, targeted, oral biotherapeutic for celiac disease; capeserod, a selective 5-HT4 receptor partial agonist for indications including gastroparesis; and adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis and chronic pancreatitis patients with exocrine pancreatic insufficiency.

About MYSE Myseum Inc.

Myseum Inc is a blockchain, cybersecurity, and social media company that not only focuses on protecting privacy on personal devices, but also protects user information after it is shared with others. Its mobile messaging application is called DatChat Messenger which is a free messaging application. The platform allows users to exercise control over their messages and posts.

Share on Social Networks: